Stromal control of oncogenic traits expressed in response to the overexpression of GLI2, a pleiotropic oncogene

Oncogene

Volumn 28, Issue 5, 2009, Pages 625-637

  Snijders, A M ^a,b   Huey, B ^b,c   Connelly, S T ^a   Roy, R ^b   Jordan, R C K ^a,b   Schmidt, B L ^b,c   Albertson, D G ^a,b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

GLI2; Invasion; Organotypic culture; Transdifferentiation

Indexed keywords

TRANSCRIPTION FACTOR SOX2; TRANSFORMING GROWTH FACTOR BETA1;

ADOLESCENT; ADULT; ARTICLE; CELL GROWTH; CELL INVASION; CELL TRANSDIFFERENTIATION; CONTROLLED STUDY; FIBROBLAST; GENE AMPLIFICATION; GENE OVEREXPRESSION; GENOMIC INSTABILITY; GL12 GENE; HUMAN; HUMAN CELL; HUMAN TISSUE; MOUTH CARCINOMA; MYOFIBROBLAST; ONCOGENE; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; STROMA; TUMOR CELL; UPREGULATION;

ADOLESCENT; ADULT; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; CELLS, CULTURED; GENE AMPLIFICATION; GENOMIC INSTABILITY; HUMANS; KERATINOCYTES; KRUPPEL-LIKE TRANSCRIPTION FACTORS; NEOPLASMS; NUCLEAR PROTEINS; ONCOGENES; ORGAN SPECIFICITY; STROMAL CELLS; UP-REGULATION; YOUNG ADULT;

ERINACEIDAE;

EID: 59649111693     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2008.421     Document Type: Article

References (53)

1. Albertson DG, Collins C, McCormick F, Gray JW. (2003). Chromosome aberrations in solid tumors. Nat Genet 34: 369-376.
2. Bartkova J, Horejsi Z, Koed K, Kramer A, Tort F, Zieger K et al. (2005). DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature 434: 864-870.
3. Bell E, Ehrlich HP, Buttle DJ, Nakatsuji T. (1981). Living tissue formed in vitro and accepted as skin-equivalent tissue of full thickness. Science 211: 1052-1054.
4. Ben-Porath I, Thomson MW, Carey VJ, Ge R, Bell GW, Regev A et al. (2008). An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat Genet 40: 499-507.
5. Bigelow RL, Jen EY, Delehedde M, Chari NS, McDonnell TJ. (2005). Sonic hedgehog induces epidermal growth factor dependent matrix infiltration in HaCaT keratinocytes. J Invest Dermatol 124: 457-465.
6. Black Jr SA, Palamakumbura AH, Stan M, Trackman PC. (2007). Tissue-specific mechanisms for CCN2/CTGF persistence in fibrotic gingiva: interactions between cAMP and MAPK signaling pathways, and prostaglandin E2-EP3 receptor mediated activation of the c-JUN N-terminal kinase. J Biol Chem 282: 15416-15429.
7. Boukamp P, Petrussevska RT, Breitkreutz D, Hornung J, Markham A, Fusenig NE. (1988). Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J Cell Biol 106: 761-771.
8. Burnworth B, Popp S, Stark HJ, Steinkraus V, Brocker EB, Hartschuh W et al. (2006). Gain of 11q/cyclin D1 overexpression is an essential early step in skin cancer development and causes abnormal tissue organization and differentiation. Oncogene 25: 4399-4412.
9. Cerezo A, Stark HJ, Moshir S, Boukamp P. (2003). Constitutive overexpression of human telomerase reverse transcriptase but not cmyc blocks terminal differentiation in human HaCaT skin keratinocytes. J Invest Dermatol 121: 110-119.
10. Chang HY, Chi JT, Dudoit S, Bondre C, van de Rijn M, Botstein D et al. (2002). Diversity, topographic differentiation, and positional memory in human fibroblasts. Proc Natl Acad Sci USA 99: 12877-12882.
11. Chen Y, Shi L, Zhang L, Li R, Liang J, Yu W et al. (2008). The molecular mechanism governing the oncogenic potential of sox2 in breastcancer. J Biol Chem 283: 17969-17978.
12. Clement V, Sanchez P, de Tribolet N, Radovanovic I, Ruiz i Altaba A. (2007). HEDGEHOG-GLI1 signaling regulates human glioma growth, cancer stem cell self-renewal, and tumorigenicity. Curr Biol 17: 165-172.
13. De Wever O, Mareel M. (2003). Role of tissue stroma in cancer cell invasion. J Pathol 200: 429-447.
14. Delehedde M, Cho SH, Hamm R, Brisbay S, Ananthaswamy HN, Kripke M et al. (2001). Impactof Bcl-2 and Ha-ras on keratinocytes in organotypic culture. J Invest Dermatol 116: 366-373.
15. Fridlyand J, Snijders AM, Ylstra B, Li H, Olshen A, Segraves R et al. (2006). Breast tumor copy number aberration phenotypes and genomic instability. BMC Cancer 6: 96.
16. Gorgoulis VG, Vassiliou LV, Karakaidos P, Zacharatos P, Kotsinas A, Liloglou T et al. (2005). Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions. Nature 434: 907-913.
17. Grachtchouk V, Grachtchouk M, Lowe L, Johnson T, Wei L, Wang A et al. (2003). The magnitude of hedgehog signaling activity defines skin tumor phenotype. EMBO J 22: 2741-2751.
18. Hanahan D, Weinberg RA. (2000). The hallmarks of cancer. Cell 100: 57-70.
19. Hooper JE, Scott MP. (2005). Communicating with Hedgehogs. Nat Rev Mol Cell Biol 6: 306-317.
20. Izzo JG, Papadimitrakopoulou VA, Li XQ, Ibarguen H, Lee JS, Ro JY et al. (1998). Dysregulated cyclin D1 expression early in head and neck tumorigenesis: in vivo evidence for an association with subsequentgene amplification. Oncogene 17: 2313-2322.
21. Kalluri R, Zeisberg M. (2006). Fibroblasts in cancer. Nat Rev Cancer 6: 392-401.
22. Kellermann MG, Sobral LM, da Silva SD, Zecchin KG, Graner E, Lopes MA et al. (2008). Mutual paracrine effects of oral squamous cell carcinoma cells and normal oral fibroblasts: Induction of fibroblast to myofibroblast transdifferentiation and modulation of tumor cell proliferation. Oral Oncol 44: 509-517.
23. Kendall J, Liu Q, Bakleh A, Krasnitz A, Nguyen KC, Lakshmi B et al. (2007). Oncogenic cooperation and coamplification of developmental transcription factor genes in lung cancer. Proc Natl Acad Sci USA 104: 16663-16668.
24. Kwei KA, Kim YH, Girard L, Kao J, Pacyna-Gengelbach M, Salari K et al. (2008). Genomic profiling identifies TITF1 as a lineage-specific oncogene amplified in lung cancer. Oncogene 27: 3635-3640.
25. Lacher MD, Tiirikainen MI, Saunier EF, Christian C, Anders M, Oft M et al. (2006). Transforming growth factor-beta receptor inhibition enhances adenoviral infectability of carcinoma cells via up-regulation of coxsackie and adenovirus receptor in conjunction with reversal of epithelial-mesenchymal transition. Cancer Res 66: 1648-1657.
26. Lauth M, Bergstrom A, Shimokawa T, Toftgard R. (2007). Inhibition of GLI-mediated transcription and tumor cell growth by small-molecule antagonists. Proc Natl Acad Sci USA 104: 8455-8460.
27. Lauth M, Toftgard R. (2007). Non-canonical activation of GLI transcription factors: implications for targeted anti-cancer therapy. Cell Cycle 6: 2458-2463.
28. Lewis MP, Lygoe KA, Nystrom ML, Anderson WP, Speight PM, Marshall JF et al. (2004). Tumour-derived TGF-beta1 modulates myofibroblast differentiation and promotes HGF/SF-dependent invasion of squamous carcinoma cells. Br J Cancer 90: 822-832.
29. Marsh D, Dickinson S, Neill GW, Marshall JF, Hart IR, Thomas GJ. (2008). alpha vbeta 6 Integrin promotes the invasion of morphoeic basal cell carcinoma through stromal modulation. Cancer Res 68: 3295-3303.
30. Miele M, Bonatti S, Menichini P, Ottaggio L, Abbondandolo A. (1989). The presence of amplified regions affects the stability of chromosomes in drug-resistant Chinese hamster cells. Mutat Res 219: 171-178.
31. Mueller MM, Fusenig NE. (2004). Friends or foes - bipolar effects of the tumour stroma in cancer. Nat Rev Cancer 4: 839-849.
32. Murnane JP, Sabatier L. (2004). Chromosome rearrangements resulting from telomere dysfunction and their role in cancer. Bioessays 26: 1164-1174.
33. Neill GW, Harrison WJ, Ikram MS, Williams TD, Bianchi LS, Nadendla SK et al. (2008). GLI1 repression of ERK activity correlates with colony formation and impaired migration in human epidermal keratinocytes. Carcinogenesis 29: 738-746.
34. Nelsen CJ, Kuriyama R, Hirsch B, Negron VC, Lingle WL, Goggin MM et al. (2005). Shortt erm cyclin D1 overexpression induces centrosome amplification, mitotic spindle abnormalities, and aneuploidy. J Biol Chem 280: 768-776.
35. Okubo T, Pevny LH, Hogan BL. (2006). Sox2 is required for development of taste bud sensory cells. Genes Dev 20: 2654-2659.
36. Paulson TG, Almasan A, Brody LL, Wahl GM. (1998). Gene amplification in a p53-deficient cell line requires cell cycle progression under conditions that generate DNA breakage. Mol Cell Biol 18: 3089-3100.
37. Que J, Okubo T, Goldenring JR, Nam KT, Kurotani R, Morrisey EE et al. (2007). Multiple dose-dependent roles for Sox2 in the patterning and differentiation of anterior foregut endoderm. Development 134: 2521-2531.
38. Regl G, Kasper M, Schnidar H, Eichberger T, Neill GW, Ikram MS et al. (2004). The zinc-finger transcription factor GLI2 antagonizes contact inhibition and differentiation of human epidermal cells. Oncogene 23: 1263-1274.
39. Riobo NA, Lu K, Emerson Jr CP. (2006). Hedgehog signal transduction: signal integration and cross talk in development and cancer. Cell Cycle 5: 1612-1615.
40. Roh HJ, Shin DM, Lee JS, Ro JY, Tainsky MA, Hong WK et al. (2000). Visualization of the timing of gene amplification during multistep head and neck tumorigenesis. Cancer Res 60: 6496-6502.
41. Roth JR, Andersson DI. (2004). Amplification-mutagenesis - how growth under selection contributes to the origin of genetic diversity and explains the phenomenon of adaptive mutation. Res Microbiol 155: 342-351.
42. Schmidt BL, Dierks EJ, Homer L, Potter B. (2004). Tobacco smoking history and presentation of oral squamous cell carcinoma. J Oral Maxillofac Surg 62: 1055-1058.
43. Schoop VM, Mirancea N, Fusenig NE. (1999). Epidermal organization and differentiation of HaCaT keratinocytes in organotypic coculture with human dermal fibroblasts. J Invest Dermatol 112: 343-353.
44. Shimizu N, Shingaki K, Kaneko-Sasaguri Y, Hashizume T, Kanda T. (2005). When, where and how the bridge breaks: anaphase bridge breakage plays a crucial role in gene amplification and HSR generation. Exp Cell Res 302: 233-243.
45. Snijders AM, Fridlyand J, Mans DA, Segraves R, Jain AN, Pinkel D et al. (2003). Shaping of tumor and drug-resistant genomes by instability and selection. Oncogene 22: 4370-4379.
46. Snijders AM, Hermsen MA, Baughman J, Buffart TE, Huey B, Gajduskova P et al. (2008). Acquired genomic aberrations associated with methotrexate resistance vary with background genomic instability. Genes Chromosomes Cancer 47: 71-83.
47. Snijders AM, Schmidt BL, Fridlyand J, Dekker N, Pinkel D, Jordan RC et al. (2005). Rare amplicons implicate frequent deregulation of cell fate specification pathways in oral squamous cell carcinoma. Oncogene 24: 4232-4242.
48. Svensson S, Nilsson K, Ringberg A, Landberg G. (2003). Invade or proliferate? Two contrasting events in malignant behavior governed by p16(INK4a) and an intact Rb pathway illustrated by a model system of basal cell carcinoma. Cancer Res 63: 1737-1742.
49. Tuxhorn JA, Ayala GE, Rowley DR. (2001). Reactive stroma in prostate cancer progression. J Urol 166: 2472-2483.
50. Verona EV, Elkahloun AG, Yang J, Bandyopadhyay A, Yeh IT, Sun LZ. (2007). Transforming growth factor-beta signaling in prostate stromal cells supports prostate carcinoma growth by up-regulating stromal genes related to tissue remodeling. Cancer Res 67: 5737-5746.
51. Weir BA, Woo MS, Getz G, Perner S, Ding L, Beroukhim R et al. (2007). Characterizing the cancer genome in lung adenocarcinoma. Nature 450: 893-898.
52. Zeisberg EM, Potenta S, Xie L, Zeisberg M, Kalluri R. (2007). Discovery of endothelial to mesenchymal transition as a source for carcinoma-associated fibroblasts. Cancer Res 67: 10123-10128.
53. Zhou P, Jiang W, Weghorst CM, Weinstein IB. (1996). Overexpression of cyclin D1 enhances gene amplification. Cancer Res 56: 36-39.